0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Low-density Lipoprotein Apheresis Therapy Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-19A13313
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Low density Lipoprotein Apheresis Therapy Market Research Report 2023
BUY CHAPTERS

Global Low-density Lipoprotein Apheresis Therapy Market Research Report 2025

Code: QYRE-Auto-19A13313
Report
March 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Low-density Lipoprotein Apheresis Therapy Market

The global market for Low-density Lipoprotein Apheresis Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Low-density Lipoprotein Apheresis Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Low-density Lipoprotein Apheresis Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Low-density Lipoprotein Apheresis Therapy in Atherosclerosis Patient is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Low-density Lipoprotein Apheresis Therapy include Kaneka Pharma, B.Braun, Fresenius Medical Care, Asahi Kasei Medical, Medicap, Kawasumi Laboratories, Terumo Corporation, Haemonetics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Low-density Lipoprotein Apheresis Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Low-density Lipoprotein Apheresis Therapy.
The Low-density Lipoprotein Apheresis Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Low-density Lipoprotein Apheresis Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Low-density Lipoprotein Apheresis Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Low-density Lipoprotein Apheresis Therapy Market Report

Report Metric Details
Report Name Low-density Lipoprotein Apheresis Therapy Market
Segment by Type
  • Double Filtration LDL Apheresis Therapy
  • Cascade Filtration LDL Apheresis Therapy
Segment by Application
  • Atherosclerosis Patient
  • Obesity Patient
  • Dyslipidemia Patient
  • Coronary Heart Disease Patient
  • Carotid Artery Disease Patient
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Kaneka Pharma, B.Braun, Fresenius Medical Care, Asahi Kasei Medical, Medicap, Kawasumi Laboratories, Terumo Corporation, Haemonetics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Low-density Lipoprotein Apheresis Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Low-density Lipoprotein Apheresis Therapy Market report?

Ans: The main players in the Low-density Lipoprotein Apheresis Therapy Market are Kaneka Pharma, B.Braun, Fresenius Medical Care, Asahi Kasei Medical, Medicap, Kawasumi Laboratories, Terumo Corporation, Haemonetics

What are the Application segmentation covered in the Low-density Lipoprotein Apheresis Therapy Market report?

Ans: The Applications covered in the Low-density Lipoprotein Apheresis Therapy Market report are Atherosclerosis Patient, Obesity Patient, Dyslipidemia Patient, Coronary Heart Disease Patient, Carotid Artery Disease Patient

What are the Type segmentation covered in the Low-density Lipoprotein Apheresis Therapy Market report?

Ans: The Types covered in the Low-density Lipoprotein Apheresis Therapy Market report are Double Filtration LDL Apheresis Therapy, Cascade Filtration LDL Apheresis Therapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Double Filtration LDL Apheresis Therapy
1.2.3 Cascade Filtration LDL Apheresis Therapy
1.3 Market by Application
1.3.1 Global Low-density Lipoprotein Apheresis Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Atherosclerosis Patient
1.3.3 Obesity Patient
1.3.4 Dyslipidemia Patient
1.3.5 Coronary Heart Disease Patient
1.3.6 Carotid Artery Disease Patient
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Low-density Lipoprotein Apheresis Therapy Market Perspective (2020-2031)
2.2 Global Low-density Lipoprotein Apheresis Therapy Growth Trends by Region
2.2.1 Global Low-density Lipoprotein Apheresis Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Low-density Lipoprotein Apheresis Therapy Historic Market Size by Region (2020-2025)
2.2.3 Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Region (2026-2031)
2.3 Low-density Lipoprotein Apheresis Therapy Market Dynamics
2.3.1 Low-density Lipoprotein Apheresis Therapy Industry Trends
2.3.2 Low-density Lipoprotein Apheresis Therapy Market Drivers
2.3.3 Low-density Lipoprotein Apheresis Therapy Market Challenges
2.3.4 Low-density Lipoprotein Apheresis Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Low-density Lipoprotein Apheresis Therapy Players by Revenue
3.1.1 Global Top Low-density Lipoprotein Apheresis Therapy Players by Revenue (2020-2025)
3.1.2 Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Low-density Lipoprotein Apheresis Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Low-density Lipoprotein Apheresis Therapy Revenue
3.4 Global Low-density Lipoprotein Apheresis Therapy Market Concentration Ratio
3.4.1 Global Low-density Lipoprotein Apheresis Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Low-density Lipoprotein Apheresis Therapy Revenue in 2024
3.5 Global Key Players of Low-density Lipoprotein Apheresis Therapy Head office and Area Served
3.6 Global Key Players of Low-density Lipoprotein Apheresis Therapy, Product and Application
3.7 Global Key Players of Low-density Lipoprotein Apheresis Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Low-density Lipoprotein Apheresis Therapy Breakdown Data by Type
4.1 Global Low-density Lipoprotein Apheresis Therapy Historic Market Size by Type (2020-2025)
4.2 Global Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Type (2026-2031)
5 Low-density Lipoprotein Apheresis Therapy Breakdown Data by Application
5.1 Global Low-density Lipoprotein Apheresis Therapy Historic Market Size by Application (2020-2025)
5.2 Global Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Low-density Lipoprotein Apheresis Therapy Market Size (2020-2031)
6.2 North America Low-density Lipoprotein Apheresis Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2020-2025)
6.4 North America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Low-density Lipoprotein Apheresis Therapy Market Size (2020-2031)
7.2 Europe Low-density Lipoprotein Apheresis Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Low-density Lipoprotein Apheresis Therapy Market Size by Country (2020-2025)
7.4 Europe Low-density Lipoprotein Apheresis Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size (2020-2031)
8.2 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Low-density Lipoprotein Apheresis Therapy Market Size (2020-2031)
9.2 Latin America Low-density Lipoprotein Apheresis Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2020-2025)
9.4 Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size (2020-2031)
10.2 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Kaneka Pharma
11.1.1 Kaneka Pharma Company Details
11.1.2 Kaneka Pharma Business Overview
11.1.3 Kaneka Pharma Low-density Lipoprotein Apheresis Therapy Introduction
11.1.4 Kaneka Pharma Revenue in Low-density Lipoprotein Apheresis Therapy Business (2020-2025)
11.1.5 Kaneka Pharma Recent Development
11.2 B.Braun
11.2.1 B.Braun Company Details
11.2.2 B.Braun Business Overview
11.2.3 B.Braun Low-density Lipoprotein Apheresis Therapy Introduction
11.2.4 B.Braun Revenue in Low-density Lipoprotein Apheresis Therapy Business (2020-2025)
11.2.5 B.Braun Recent Development
11.3 Fresenius Medical Care
11.3.1 Fresenius Medical Care Company Details
11.3.2 Fresenius Medical Care Business Overview
11.3.3 Fresenius Medical Care Low-density Lipoprotein Apheresis Therapy Introduction
11.3.4 Fresenius Medical Care Revenue in Low-density Lipoprotein Apheresis Therapy Business (2020-2025)
11.3.5 Fresenius Medical Care Recent Development
11.4 Asahi Kasei Medical
11.4.1 Asahi Kasei Medical Company Details
11.4.2 Asahi Kasei Medical Business Overview
11.4.3 Asahi Kasei Medical Low-density Lipoprotein Apheresis Therapy Introduction
11.4.4 Asahi Kasei Medical Revenue in Low-density Lipoprotein Apheresis Therapy Business (2020-2025)
11.4.5 Asahi Kasei Medical Recent Development
11.5 Medicap
11.5.1 Medicap Company Details
11.5.2 Medicap Business Overview
11.5.3 Medicap Low-density Lipoprotein Apheresis Therapy Introduction
11.5.4 Medicap Revenue in Low-density Lipoprotein Apheresis Therapy Business (2020-2025)
11.5.5 Medicap Recent Development
11.6 Kawasumi Laboratories
11.6.1 Kawasumi Laboratories Company Details
11.6.2 Kawasumi Laboratories Business Overview
11.6.3 Kawasumi Laboratories Low-density Lipoprotein Apheresis Therapy Introduction
11.6.4 Kawasumi Laboratories Revenue in Low-density Lipoprotein Apheresis Therapy Business (2020-2025)
11.6.5 Kawasumi Laboratories Recent Development
11.7 Terumo Corporation
11.7.1 Terumo Corporation Company Details
11.7.2 Terumo Corporation Business Overview
11.7.3 Terumo Corporation Low-density Lipoprotein Apheresis Therapy Introduction
11.7.4 Terumo Corporation Revenue in Low-density Lipoprotein Apheresis Therapy Business (2020-2025)
11.7.5 Terumo Corporation Recent Development
11.8 Haemonetics
11.8.1 Haemonetics Company Details
11.8.2 Haemonetics Business Overview
11.8.3 Haemonetics Low-density Lipoprotein Apheresis Therapy Introduction
11.8.4 Haemonetics Revenue in Low-density Lipoprotein Apheresis Therapy Business (2020-2025)
11.8.5 Haemonetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Double Filtration LDL Apheresis Therapy
 Table 3. Key Players of Cascade Filtration LDL Apheresis Therapy
 Table 4. Global Low-density Lipoprotein Apheresis Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Low-density Lipoprotein Apheresis Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Low-density Lipoprotein Apheresis Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Low-density Lipoprotein Apheresis Therapy Market Share by Region (2020-2025)
 Table 8. Global Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Low-density Lipoprotein Apheresis Therapy Market Share by Region (2026-2031)
 Table 10. Low-density Lipoprotein Apheresis Therapy Market Trends
 Table 11. Low-density Lipoprotein Apheresis Therapy Market Drivers
 Table 12. Low-density Lipoprotein Apheresis Therapy Market Challenges
 Table 13. Low-density Lipoprotein Apheresis Therapy Market Restraints
 Table 14. Global Low-density Lipoprotein Apheresis Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Low-density Lipoprotein Apheresis Therapy Market Share by Players (2020-2025)
 Table 16. Global Top Low-density Lipoprotein Apheresis Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Low-density Lipoprotein Apheresis Therapy as of 2024)
 Table 17. Ranking of Global Top Low-density Lipoprotein Apheresis Therapy Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Low-density Lipoprotein Apheresis Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Low-density Lipoprotein Apheresis Therapy, Headquarters and Area Served
 Table 20. Global Key Players of Low-density Lipoprotein Apheresis Therapy, Product and Application
 Table 21. Global Key Players of Low-density Lipoprotein Apheresis Therapy, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Low-density Lipoprotein Apheresis Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share by Type (2020-2025)
 Table 25. Global Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share by Type (2026-2031)
 Table 27. Global Low-density Lipoprotein Apheresis Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share by Application (2020-2025)
 Table 29. Global Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share by Application (2026-2031)
 Table 31. North America Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Low-density Lipoprotein Apheresis Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Low-density Lipoprotein Apheresis Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Kaneka Pharma Company Details
 Table 47. Kaneka Pharma Business Overview
 Table 48. Kaneka Pharma Low-density Lipoprotein Apheresis Therapy Product
 Table 49. Kaneka Pharma Revenue in Low-density Lipoprotein Apheresis Therapy Business (2020-2025) & (US$ Million)
 Table 50. Kaneka Pharma Recent Development
 Table 51. B.Braun Company Details
 Table 52. B.Braun Business Overview
 Table 53. B.Braun Low-density Lipoprotein Apheresis Therapy Product
 Table 54. B.Braun Revenue in Low-density Lipoprotein Apheresis Therapy Business (2020-2025) & (US$ Million)
 Table 55. B.Braun Recent Development
 Table 56. Fresenius Medical Care Company Details
 Table 57. Fresenius Medical Care Business Overview
 Table 58. Fresenius Medical Care Low-density Lipoprotein Apheresis Therapy Product
 Table 59. Fresenius Medical Care Revenue in Low-density Lipoprotein Apheresis Therapy Business (2020-2025) & (US$ Million)
 Table 60. Fresenius Medical Care Recent Development
 Table 61. Asahi Kasei Medical Company Details
 Table 62. Asahi Kasei Medical Business Overview
 Table 63. Asahi Kasei Medical Low-density Lipoprotein Apheresis Therapy Product
 Table 64. Asahi Kasei Medical Revenue in Low-density Lipoprotein Apheresis Therapy Business (2020-2025) & (US$ Million)
 Table 65. Asahi Kasei Medical Recent Development
 Table 66. Medicap Company Details
 Table 67. Medicap Business Overview
 Table 68. Medicap Low-density Lipoprotein Apheresis Therapy Product
 Table 69. Medicap Revenue in Low-density Lipoprotein Apheresis Therapy Business (2020-2025) & (US$ Million)
 Table 70. Medicap Recent Development
 Table 71. Kawasumi Laboratories Company Details
 Table 72. Kawasumi Laboratories Business Overview
 Table 73. Kawasumi Laboratories Low-density Lipoprotein Apheresis Therapy Product
 Table 74. Kawasumi Laboratories Revenue in Low-density Lipoprotein Apheresis Therapy Business (2020-2025) & (US$ Million)
 Table 75. Kawasumi Laboratories Recent Development
 Table 76. Terumo Corporation Company Details
 Table 77. Terumo Corporation Business Overview
 Table 78. Terumo Corporation Low-density Lipoprotein Apheresis Therapy Product
 Table 79. Terumo Corporation Revenue in Low-density Lipoprotein Apheresis Therapy Business (2020-2025) & (US$ Million)
 Table 80. Terumo Corporation Recent Development
 Table 81. Haemonetics Company Details
 Table 82. Haemonetics Business Overview
 Table 83. Haemonetics Low-density Lipoprotein Apheresis Therapy Product
 Table 84. Haemonetics Revenue in Low-density Lipoprotein Apheresis Therapy Business (2020-2025) & (US$ Million)
 Table 85. Haemonetics Recent Development
 Table 86. Research Programs/Design for This Report
 Table 87. Key Data Information from Secondary Sources
 Table 88. Key Data Information from Primary Sources
 Table 89. Authors List of This Report


List of Figures
 Figure 1. Low-density Lipoprotein Apheresis Therapy Picture
 Figure 2. Global Low-density Lipoprotein Apheresis Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Low-density Lipoprotein Apheresis Therapy Market Share by Type: 2024 VS 2031
 Figure 4. Double Filtration LDL Apheresis Therapy Features
 Figure 5. Cascade Filtration LDL Apheresis Therapy Features
 Figure 6. Global Low-density Lipoprotein Apheresis Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Low-density Lipoprotein Apheresis Therapy Market Share by Application: 2024 VS 2031
 Figure 8. Atherosclerosis Patient Case Studies
 Figure 9. Obesity Patient Case Studies
 Figure 10. Dyslipidemia Patient Case Studies
 Figure 11. Coronary Heart Disease Patient Case Studies
 Figure 12. Carotid Artery Disease Patient Case Studies
 Figure 13. Low-density Lipoprotein Apheresis Therapy Report Years Considered
 Figure 14. Global Low-density Lipoprotein Apheresis Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Low-density Lipoprotein Apheresis Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Low-density Lipoprotein Apheresis Therapy Market Share by Region: 2024 VS 2031
 Figure 17. Global Low-density Lipoprotein Apheresis Therapy Market Share by Players in 2024
 Figure 18. Global Top Low-density Lipoprotein Apheresis Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Low-density Lipoprotein Apheresis Therapy as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Low-density Lipoprotein Apheresis Therapy Revenue in 2024
 Figure 20. North America Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Low-density Lipoprotein Apheresis Therapy Market Share by Country (2020-2031)
 Figure 22. United States Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Low-density Lipoprotein Apheresis Therapy Market Share by Country (2020-2031)
 Figure 26. Germany Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Share by Region (2020-2031)
 Figure 34. China Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Low-density Lipoprotein Apheresis Therapy Market Share by Country (2020-2031)
 Figure 42. Mexico Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Share by Country (2020-2031)
 Figure 46. Turkey Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Kaneka Pharma Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2020-2025)
 Figure 50. B.Braun Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2020-2025)
 Figure 51. Fresenius Medical Care Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2020-2025)
 Figure 52. Asahi Kasei Medical Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2020-2025)
 Figure 53. Medicap Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2020-2025)
 Figure 54. Kawasumi Laboratories Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2020-2025)
 Figure 55. Terumo Corporation Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2020-2025)
 Figure 56. Haemonetics Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2020-2025)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart